All Stories

  1. How genetic findings in cerebral palsy can impact treatment
  2. eIF2α phosphorylation evokes dystonia-like movements with D2-receptor and cholinergic origin and abnormal neuronal connectivity
  3. Clinical utility of a genetic diagnosis in individuals with cerebral palsy and related motor disorders
  4. TRAPPC6B biallelic variants cause a neurodevelopmental disorder with TRAPP II and trafficking disruptions
  5. Clinical actionability of genetic findings in cerebral palsy
  6. AGAP1-associated endolysosomal trafficking abnormalities link gene–environment interactions in neurodevelopmental disorders
  7. Intrathecal magnesium delivery for Mg++-insensitive NMDA receptor activity due to GRIN1 mutation
  8. A transposase-derived gene required for human brain development
  9. Molecular Diagnostic Yield of Exome Sequencing and Chromosomal Microarray in Cerebral Palsy
  10. Underrepresentation of the term cerebral palsy in clinical genetics databases
  11. Mutation in ZDHHC15 Leads to Hypotonic Cerebral Palsy, Autism, Epilepsy, and Intellectual Disability
  12. Insights From Genetic Studies of Cerebral Palsy
  13. Author Correction: Mutations disrupting neuritogenesis genes confer risk for cerebral palsy
  14. Mutations disrupting neuritogenesis genes confer risk for cerebral palsy
  15. Cataplexy in Patients Harboring the KCNMA1 p.N999S Mutation
  16. Damaging de novo missense variants inEEF1A2lead to a developmental and degenerative epileptic‐dyskinetic encephalopathy
  17. Genetic or Other Causation Should Not Change the Clinical Diagnosis of Cerebral Palsy
  18. Spontaneous alternation: A potential gateway to spatial working memory in Drosophila